• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interactions between drugs and occupied receptors.药物与被占据受体之间的相互作用。
Pharmacol Ther. 2007 Jan;113(1):197-209. doi: 10.1016/j.pharmthera.2006.08.002. Epub 2006 Sep 7.
2
Assessment of non-linear combination effect terms for drug-drug interactions.药物相互作用的非线性组合效应项评估。
J Pharmacokinet Pharmacodyn. 2016 Oct;43(5):461-79. doi: 10.1007/s10928-016-9490-0. Epub 2016 Sep 16.
3
New insight into isobolographic analysis for combinations of a full and partial agonist: Curved isoboles.全新视角下的完全激动剂和部分激动剂联合作用的量效关系分析:曲线型等效应线。
Toxicology. 2018 Jun 1;402-403:9-16. doi: 10.1016/j.tox.2018.04.004. Epub 2018 Apr 13.
4
The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.协同性对解离常数测定的影响:对程-普鲁索夫方程、斯卡查德分析、希尔分析及相关幂方程的考察
Pharmacol Res. 2004 Jul;50(1):21-40. doi: 10.1016/j.phrs.2003.11.007.
5
pA2 and receptor differentiation: a statistical analysis of competitive antagonism.亲和力指数(pA2)与受体区分:竞争性拮抗作用的统计分析
Life Sci. 1979 Aug 20;25(8):637-54. doi: 10.1016/0024-3205(79)90505-8.
6
Drug interactions.药物相互作用。
Am Fam Physician. 1983 Feb;27(2):229-38.
7
The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.药物剂量等效性在受体占有率和药物组合的定量分析中的应用。
Pharmacol Ther. 2010 Aug;127(2):165-74. doi: 10.1016/j.pharmthera.2010.04.011. Epub 2010 May 28.
8
Receptor theories and quantitative effect versus dose-concentration relationship.受体理论以及效应与剂量 - 浓度的定量关系。
Drug Metab Rev. 1984;15(1-2):345-63. doi: 10.3109/03602538409015071.
9
The use of drug-receptor affinity measures in the differentiation of receptors.药物-受体亲和力测定在受体鉴别中的应用。
Fed Proc. 1982 May;41(7):2323-7.
10
The classification of drugs and drug receptors in isolated tissues.离体组织中药物及药物受体的分类
Pharmacol Rev. 1984 Sep;36(3):165-222.

引用本文的文献

1
Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures.伊维菌素增强了紫杉醇在三维细胞培养的高级别浆液性癌中的有效性。
Pharmaceuticals (Basel). 2024 Dec 25;18(1):14. doi: 10.3390/ph18010014.
2
Schild Analysis of the Interaction between Parthenolide and Cocaine Suggests an Allosteric Relationship for Their Effects on Planarian Motility.Schild 分析表明,小白菊内酯与可卡因对涡虫运动的影响存在变构关系。
Biomolecules. 2024 Sep 18;14(9):1168. doi: 10.3390/biom14091168.
3
AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.AM1172(一种水解抗性内源性大麻素类似物,可抑制花生四烯酸酰胺细胞摄取)降低了各种黑素瘤细胞的活力,但对健康细胞有显著的细胞毒性作用:基于等辐射分析的体外研究。
Pharmacol Rep. 2024 Feb;76(1):154-170. doi: 10.1007/s43440-023-00557-2. Epub 2023 Nov 29.
4
Imperatorin interacts additively with novel antiseizure medications in the mouse maximal electroshock-induced seizure model: an isobolographic transformation.小白拟雌内酯与新型抗癫痫药物在小鼠最大电休克惊厥模型中呈相加作用:立体化学转化。
Pharmacol Rep. 2024 Feb;76(1):216-222. doi: 10.1007/s43440-023-00555-4. Epub 2023 Nov 28.
5
The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line.卡铂联合匹伐他汀或二甲双胍增强耐药性高级别浆液性卵巢癌细胞系的抗肿瘤作用。
Int J Mol Sci. 2022 Dec 21;24(1):97. doi: 10.3390/ijms24010097.
6
Isobolographic analysis of adjunct antiseizure activity of the FDA-approved cannabidiol with neurosteroids and benzodiazepines in adult refractory focal onset epilepsy.成人大脑局灶性起始癫痫耐药患者中,美国食品药品监督管理局批准的大麻二酚与神经甾体和苯二氮䓬类药物辅助抗癫痫作用的协同作用分析。
Exp Neurol. 2023 Feb;360:114294. doi: 10.1016/j.expneurol.2022.114294. Epub 2022 Dec 6.
7
Isoquinoline Alkaloids from Franch: Focus on Coptisine as a Potential Therapeutic Candidate against Gastric Cancer Cells.黄连中的异喹啉生物碱:以小檗碱为靶点治疗胃癌细胞。
Int J Mol Sci. 2022 Sep 7;23(18):10330. doi: 10.3390/ijms231810330.
8
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma.匹伐他汀和伊维菌素增强紫杉醇对化疗耐药性高级别浆液性癌的疗效。
Cancers (Basel). 2022 Sep 7;14(18):4357. doi: 10.3390/cancers14184357.
9
Additive Interactions between Betulinic Acid and Two Taxanes in In Vitro Tests against Four Human Malignant Melanoma Cell Lines.桦木酸与两种紫杉烷类化合物在体外对四种人恶性黑素瘤细胞系的协同作用。
Int J Mol Sci. 2022 Aug 25;23(17):9641. doi: 10.3390/ijms23179641.
10
Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells.Sirtuin 抑制剂 cambinol 与紫杉醇在 MCF7 腔细胞系和 MDA-MB-231 三阴性乳腺癌细胞中的相加性药物相互作用。
Pharmacol Rep. 2022 Oct;74(5):1011-1024. doi: 10.1007/s43440-022-00393-w. Epub 2022 Jul 28.

本文引用的文献

1
pA, a new scale for the measurement of drug antagonism.pA,一种测量药物拮抗作用的新尺度。
Br J Pharmacol Chemother. 1947 Sep;2(3):189-206. doi: 10.1111/j.1476-5381.1947.tb00336.x.
2
An overview of drug combination analysis with isobolograms.用等效线图进行药物联合分析概述。
J Pharmacol Exp Ther. 2006 Oct;319(1):1-7. doi: 10.1124/jpet.106.104117. Epub 2006 May 2.
3
Isobolographic analysis for combinations of a full and partial agonist: curved isoboles.对完全激动剂和部分激动剂组合的等效线分析:曲线等效线
J Pharmacol Exp Ther. 2004 Sep;310(3):981-6. doi: 10.1124/jpet.104.067264. Epub 2004 Jun 2.
4
Some quantitative uses of drug antagonists.药物拮抗剂的一些定量应用。
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.
5
The problem of synergism and antagonism of combined drugs.联合用药的协同和拮抗问题。
Arzneimittelforschung. 1953 Jun;3(6):285-90.
6
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice.口服氨基葡萄糖与非阿片类镇痛药联合使用对小鼠的抗伤害感受协同作用、相加作用和亚相加作用。
J Pharmacol Exp Ther. 2003 Nov;307(2):699-704. doi: 10.1124/jpet.103.054320. Epub 2003 Sep 9.
7
Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain.加巴喷丁与神经激肽(1)受体拮抗剂CI - 1021在两种神经性疼痛大鼠模型中具有协同作用。
J Pharmacol Exp Ther. 2002 Nov;303(2):730-5. doi: 10.1124/jpet.102.033134.
8
Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.μ阿片样物质配体之间的协同作用:μ阿片样物质受体亚型间功能相互作用的证据
J Pharmacol Exp Ther. 2002 Nov;303(2):557-62. doi: 10.1124/jpet.102.035881.
9
N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia.N-甲基-D-天冬氨酸拮抗剂与WIN 55212-2[4,5-二氢-2-甲基-4(4-吗啉基甲基)-1-(1-萘甲酰基)-6H-吡咯并[3,2,1-i,j]喹啉-6-酮](一种大麻素激动剂)相互作用产生协同性体温过低。
J Pharmacol Exp Ther. 2002 Oct;303(1):395-402. doi: 10.1124/jpet.102.037473.
10
The interaction index: a measure of drug synergism.相互作用指数:一种药物协同作用的度量方法。
Pain. 2002 Jul;98(1-2):163-8. doi: 10.1016/s0304-3959(02)00041-6.

药物与被占据受体之间的相互作用。

Interactions between drugs and occupied receptors.

作者信息

Tallarida Ronald J

机构信息

Department of Pharmacology, and Center on Substance Research, Temple University School of Medicine, Philadelphia, PA 19149, USA.

出版信息

Pharmacol Ther. 2007 Jan;113(1):197-209. doi: 10.1016/j.pharmthera.2006.08.002. Epub 2006 Sep 7.

DOI:10.1016/j.pharmthera.2006.08.002
PMID:17079019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2045509/
Abstract

This review has 2 parts. Part I deals with isobolographic procedures that are traditionally applied to the joint action of agonists that individually produce overtly similar effects. Special attention is directed to newer computational procedures that apply to agonists with dissimilar concentration-effect curves. These newer procedures are consistent with the isobolographic methods introduced and used by Loewe, however, the present communications provides the needed graphical and mathematical detail. A major aim is distinguishing super and sub-addictive interactions from those that are simply additive. The detection and measurement of an interaction is an important step in exploring drug mechanism and is also important clinically. Part II discusses a new use of isoboles that is applicable to a single drug or chemical whose effect is mediated by 2 or more receptor subtypes. This application produces a metric that characterizes the interaction between the receptor subtypes. The expansion of traditional isobolographic theory to this multi-receptor situation follows from the newer approaches for 2-drug combination analysis in Part I. This topic leads naturally to a re-examination of competitive antagonism and the classic Schild plot. In particular, it is shown here that the Schild plot in the multi-receptor case is not necessarily linear with unit slope. Both parts of this review emphasize the quantitative aspects rather than the many drugs that have been analyzed with isobolographic methods. The mathematical exposition is rather elementary and is further aided by several graphs. An appendix is included for the reader interested in the mathematical details.

摘要

本综述分为两部分。第一部分讨论等效线图法,该方法传统上应用于单独产生明显相似效应的激动剂的联合作用。特别关注适用于具有不同浓度 - 效应曲线的激动剂的新计算方法。这些新方法与洛伊引入和使用的等效线图法一致,然而,本通讯提供了所需的图形和数学细节。一个主要目的是区分超相加和亚相加相互作用与简单相加的相互作用。相互作用的检测和测量是探索药物作用机制的重要一步,在临床上也很重要。第二部分讨论等效线的一种新用途,它适用于其效应由两种或更多种受体亚型介导的单一药物或化学物质。这种应用产生了一种表征受体亚型之间相互作用的指标。将传统等效线图理论扩展到这种多受体情况是基于第一部分中二维药物组合分析的新方法。这个主题自然地引出了对竞争性拮抗作用和经典希尔德图的重新审视。特别是,这里表明在多受体情况下希尔德图不一定具有单位斜率的线性关系。本综述的两部分都强调定量方面,而不是用等效线图法分析的众多药物。数学阐述相当基础,并辅以几幅图表。附录为对数学细节感兴趣的读者而设。